Allergan to make five presentations at the AUA annual meeting
Allergan to present data on overactive bladder, nocturia and ulcerative interstitial cystitis at the AUA meeting this weekend. Read More »
UsAgainstAlzheimer announces support for Phase III clinical trial
Eli Lilly's and AstraZeneca's BACE inhibitor drug for Alzheimer's advancing to Phase III clinical trial. Read More »
Cigna and Rush Health collaborate to improve services for plan members
The collaboration is designed to improve services for Cigna health plan members who receive care from Rush Health professionals. Read More »
FDA approves drug to treat Parkinson's disease hallucinations and delusions
Nuplazid has been approved to treat the hallucinations and delusions experienced by some Parkinson's disease patients. Read More »
Allergan to provide affordable birth control for women in the military
"LILETTA Access on the Front Line" to increase access to IUDs for U.S. military women. Read More »
First generic version of Crestor approved
The FDA approved the first generic version of Crestor last week. Read More »
CHMP issues positive decision for new antibiotic
AstraZeneca announced the positive decision for CAZ AVI by CHMP. Read More »
New hope for EPI patients in the EU
CHMP issues positive opinion on Allergan's ENZEPI for patients with EPI Read More »
Congress examines tax code and its effects on health care
Ways and Means Committee held a hearing recently to discuss health care challenges and explore opportunities for improvement. Read More »
Prime researches 'insulin shock' and ER visits
Low blood sugar can lead to ER visits; Prime releases research on hypoglycemic events. Read More »
CVS committed to National Prescription Drug Take Back Day
CVS supports Drug Take Back Day on April 30 with events and education. Read More »
Life-saving naloxone available without a prescription at New Hampshire CVS Pharmacies
Naloxone saves lives by reversing opioid overdoses; CVS makes it available for friends and family. Read More »
Sanofi US announces collaborations with DCRI and CATCH
The collaborations will create tools to predict how type 2 diabetics will follow their medication plans. Read More »
NACDS applauds access to pharmacy services provision in CMS final rule
CMS included pharmacies as key providers in the Medicaid and CHIP Managed Care final rule. Read More »
Cigna commits $2 million to World of Difference grants
Nonprofit partners providing Community Health Navigation will be a priority when awarding the grants. Read More »
APhA supports National Prescription Drug Take Back Day Initiative
Consumers can safely dispose of unused prescription drugs during National Prescription Drug Take Back Day. Read More »
NACDS annual meeting builds relationships
The annual conference allows executives from retailers, suppliers and other health care providers an opportunity to network and build relationships. Read More »
Oasmia announces positive Phase III results in ovarian cancer treatment
Overall survival rates positive in the Phase III study of epithelial ovarian cancer treatment. Read More »
Allergan announces presentations at the ARVO annual meeting
Allergan to present results of its studies at the ARVO meeting next week. Read More »
Pfizer announces SPIRE-2 clinical trial is full
The clinical trial will test bococizumab versus a placebo in reducing the risk of a major cardiovascular event. Read More »
Alerts Sign-up